| abstract |
IT REFERS TO A COMPOSITION THAT INCLUDES i) AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT (API) SUCH AS ZOLEDRONIC ACID, AND ii) A MOLECULAR COMPLEX CONFORMER THAT INCREASES THE ORAL BIODAVAILABILITY OF THE API, WHERE THE TWO FORM IS A MIXTURE OF THE TWO. MOLECULAR COMPLEX CONSISTING OF ZOLEDRONIC ACID, DL-LYSINE AND WATER. SUCH COMPOSITION IS IN ORAL DOSAGE FORM AS TABLETS OR CAPSULES THAT HAVE ENTERIC COATING |